The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice
Open accessAbstract
Interleukin-2 (IL-2)-deficient mice have cytoarchitectural hippocampal modifications and impaired learning and memory ability reminiscent of Alzheimer's disease. IL-2 stimulates regulatory T cells whose role is to control inflammation. As neuroinflammation contributes to neurodegeneration, we investigated IL-2 in Alzheimer's disease. Therefore, we investigated IL-2 levels in hippocampal biopsies of patients with Alzheimer's disease relative to age-matched control individuals. We then treated APP/PS1ΔE9 mice having established Alzheimer's disease with IL-2 for 5 months using single administration of an AAV-IL-2 vector. We first found decreased IL-2 levels in hippocampal biopsies of patients with Alzheimer's disease. In mice, IL-2-induced systemic and brain regulatory T cells expansion and activation. In the hippocampus, IL-2 induced astrocytic activation and recruitment of astrocytes around amyloid plaques, decreased amyloid-β42/40 ratio and amyloid plaque load, improved synaptic plasticity and significantly rescued spine density. Of note, this tissue remodelling was associated with recovery of memory deficits, as assessed in the Morris water maze task. Altogether, our data strongly suggest that IL-2 can alleviate Alzheimer's disease hallmarks in APP/PS1ΔE9 mice with established pathology. Therefore, this should prompt the investigation of low-dose IL-2 in Alzheimer's disease and other neuroinflammatory/neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“IL-2 rescues impaired synaptic plasticity and restores decreased spine density in APP/PS1 E9 mice Amyloid-b-induced damage of synaptic transmission is one probable mechanism inducing memory impairments in APPP/S1 mice (Snyder et al., 2005).”
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Revisiting the Mechanisms of CNS Immune Privilege
Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682
Research works printed but not linked: 50
- 10.1002/jnr.490350310 · DOI
- 10.2337/db13-0214 · DOI
- 10.1016/j.bbi.2003.09.013 · DOI
- Barcia, 2013, Imaging the microanatomy of astrocyte-T-cell interactions in immune-mediated inflammation, Front Cell Neurosci, 7, 58, 10.3389/fncel.2013.00058 · DOI
- 10.1073/pnas.1015239108 · DOI · Paper page
- Beck, 2005, IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins, J Neuroimmunol, 160, 146, 10.1016/j.jneuroim.2004.11.006 · DOI
- Beloosesky, 2002, Cytokine levels and phagocytic activity in patients with Alzheimer's disease, Gerontology, 48, 128, 10.1159/000052830 · DOI
- 10.1186/1742-2094-11-25 · DOI
- 10.1001/jamadermatol.2014.504 · DOI · Paper page
- 10.1186/1750-1326-6-16 · DOI · Paper page
- 10.1016/j.neuron.2014.11.020 · DOI · Paper page
- 10.1038/mp.2008.105 · DOI · Paper page
- 10.1016/j.clim.2014.02.003 · DOI
- 10.1016/j.jri.2007.06.051 · DOI
- 10.1093/brain/awv408 · DOI · Paper page
- Eizenberg, 1995, Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes, J Neurochem, 64, 1928, 10.1046/j.1471-4159.1995.64051928.x · DOI
- 10.1016/S0306-4522(97)00040-7 · DOI
- 10.1016/S2213-8587(13)70113-X · DOI · Paper page
- He, 2016, Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus, Nat Med, 22, 991, 10.1038/nm.4148 · DOI · Paper page
- 10.3109/10799899909036638 · DOI · Paper page
- 10.1038/ni.3102 · DOI · Paper page
- 10.1002/emmm.201201544 · DOI · Paper page
- 10.1096/fj.10-155317 · DOI · Paper page
- 10.1038/gt.2011.126 · DOI · Paper page
- 10.1038/nri3823 · DOI · Paper page
- 10.1037/0735-7044.113.5.1030 · doi:10.1037/0735-7044.113.5.1030
- 10.1038/embor.2013.117 · DOI
- 10.1186/s12974-015-0243-6 · DOI
- 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
- 10.1016/j.neurobiolaging.2012.02.015 · DOI
- 10.1016/S1471-4914(03)00109-6 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.0.CO;2-G · doi:10.1002/(sici)1097-4547(19990515)56:4<441::aid-jnr11>3.0.co;2-g
- Petitto, 2015, Effects of brain-derived IL–2 deficiency and the development of autoimmunity on spatial learning and fear conditioning, J Neurol Disord, 3, 196, 10.4172/2329-6895.1000196 · DOI
- 10.1002/glia.20599 · DOI · Paper page
- 10.1016/j.jaut.2015.01.001 · DOI · Paper page
- 10.1056/NEJMoa1105143 · DOI · Paper page
- 10.1016/j.cell.2008.05.009 · DOI · Paper page
- Sarder, 1993, Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain, Brain Res, 625, 347, 10.1016/0006-8993(93)91080-C · DOI
- 10.1016/0006-8993(95)01291-5 · doi:10.1016/0006-8993(95)01291-5
- Schwab, 2008, Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders, J Alzheimers Dis, 13, 359, 10.3233/JAD-2008-13402 · DOI · Paper page
- Shao, 1997, Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study, J Neuropathol Exp Neurol, 56, 376, 10.1097/00005072-199704000-00006 · DOI
- 10.1002/ar.21118 · DOI
- 10.1016/j.neuron.2006.01.022 · DOI · Paper page
- 10.1196/annals.1403.002 · DOI · Paper page
- 10.1038/jcbfm.2014.125 · DOI · Paper page
- 10.1038/nm.2965 · DOI · Paper page
- 10.1016/0361-9230(94)90005-1 · DOI
- 10.1038/nbt1073 · DOI · Paper page
- 10.1038/ni.1818 · DOI · Paper page
- 10.1046/j.1471-4159.2003.02018.x · DOI
Cited by
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023) · Inflammation · doi:10.1007/s10753-022-01721-1 · Cited by 557
“Hence, in an AD model, blocking IL-1β could protect from cognitive deficits and decrease tau pathology [34].”
BackgroundLuo, R., Su, L.-Y., Li, G., Yang, J., Liu, Q., Yang, L.-X., Zhang, D.-F., Zhou, H., Xu, M., Fan, Y., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1596488 · Cited by 364
Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351
Metadata
- Authors
- Alves, S., Churlaud, G., Audrain, M., Michaelsen-Preusse, K., Fol, R., Souchet, B., Braudeau, J., Korte, M., Klatzmann, D., & Cartier, N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-20
- Volume
- 140
- Issue
- 3
- Pages
- aww330
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2561221875
- Cited by
- 172
- References
- 22
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice. https://app.cochat.ai/papers/10.1093/brain/aww330
- The paper
- Alves, S., Churlaud, G., Audrain, M., Michaelsen-Preusse, K., Fol, R., Souchet, B., Braudeau, J., Korte, M., Klatzmann, D., & Cartier, N. (2016). Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice. Brain. https://doi.org/10.1093/brain/aww330
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.